Bacterial Vaginosis and Preterm Birth

Journal of Midwifery and Women's Health

Volumn 56, Issue 6, 2011, Pages 575-583

  Manns James, Laura ^a,b  

^a Frontier Nursing University   (United States)

^b KENT STATE UNIVERSITY   (United States)

Author keywords

Bacterial vaginosis; Gynecology; Health disparities; Obstetric complications; Pharmacology; Preterm birth

Indexed keywords

ACETYLCYSTEINE; CLINDAMYCIN; HYDROXYPROGESTERONE CAPROATE; METRONIDAZOLE; PLACEBO;

CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FLUSHING; GRAM STAINING; HEART PALPITATION; HUMAN; INFECTION RISK; LOOSE FECES; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PH MEASUREMENT; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; TREATMENT DURATION; VAGINITIS;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; RISK FACTORS; VAGINOSIS, BACTERIAL;

EID: 80855144406     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/j.1542-2011.2011.00086.x     Document Type: Review

References (68)

1. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med. 1995;333(26 part 1):1737-1742.
2. Goldenberg RL, Iams JD, Mercer BM, et al. The Preterm Prediction Study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health. 1998;88(2):233-238.
3. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007(1):CD000262. doi.
4. Tolosa JE, Chaithongwongwatthana S, Daly S, et al. The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynecol. 2006;195(5):1198-1204.
5. Donders GG. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):355-373.
6. Donati L, Di Vico A, Nucci M, et al. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet. 2010;281(4):589-600.
7. Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis. 2009;22(1):82-86.
8. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004: associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34(11):864-869.
9. Marrazzo JM, Thomas KK, Agnew K, Ringwood K. Prevalence and risks for bacterial vaginosis in women who have sex with women. Sex Transm Dis. 2010;37(5):335-339.
10. Romoren M, Velauthapillai M, Rahman M, Sundby J, Klouman E, Hjortdahl P. Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach. Bull World Health Organ. 2007;85(4):297-304.
11. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol. 2007;109(1):114-120.
12. Klebanoff MA, Hillier SL, Nugent RP, et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol. 2005;192(2):470-477.
13. Svare JA, Schmidt H, Hansen BB, Lose G. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG. 2006;113(12):1419-1425.
14. Lan PT, Lundborg CS, Phuc HD, et al. Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect. 2008;84(2):126-132.
15. Akinbiyi AA, Watson R, Feyi-Waboso P. Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom: outcome of a prospective study. Arch Gynecol Obstet. 2008;278(5):463-466.
16. Uscher-Pines L, Hanlon AL, Nelson DB. Racial differences in bacterial vaginosis among pregnant women: the relationship between demographic and behavioral predictors and individual BV-related microorganism levels. Matern Child Health J. 2009;13(4):512-519.
17. Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M. The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis. 2010;10:81.
18. Paul K, Boutain D, Manhart L, Hitti J. Racial disparity in bacterial vaginosis: the role of socioeconomic status, psychosocial stress, and neighborhood characteristics, and possible implications for preterm birth. Soc Sci Med. 2008;67(5):824-833.
19. Bailey JV, Farquhar C, Owen C. Bacterial vaginosis in lesbians and bisexual women. Sex Transm Dis. 2004;31(11):691-694.
20. Luong ML, Libman M, Dahhou M, et al. Vaginal douching, bacterial vaginosis, and spontaneous preterm birth. J Obstet Gynaecol Can. 2010;32(4):313-320.
21. Ryckman KK, Simhan HN, Krohn MA, Williams SM. Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod. 2009;15(2):131-137.
22. Forney LJ, Foster JA, Ledger W. The vaginal flora of healthy women is not always dominated by Lactobacillus species. J Infect Dis. 2006;194(10):1468-1469; author reply 1469-1470.
23. Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 2007;1(2):121-133.
24. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2010;108(suppl 1):4680-4687.
25. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297-301.
26. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315-1324.
27. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14-22.
28. Hogan VK, Culhane JF, Hitti J, Rauh VA, McCollum KF, Agnew KJ. Relative performance of three methods for diagnosing bacterial vaginosis during pregnancy. Matern Child Health J. 2007;11(6):532-539.
29. Verstraelen H, Verhelst R. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect Ther. 2009;7(9):1109-1124.
30. Youngkin EQ, Lester PB. Promoting self-care and secondary prevention in women's health: a study to test the accuracy of a home self-test system for bacterial vaginosis. Appl Nurs Res. 2010;23(1):2-10.
31. Madhivanan P, Krupp K, Hardin J, Karat C, Klausner JD, Reingold AL. Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings. Trop Med Int Health. 2009;14(6):703-708.
32. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1-110.
33. Waters TP, Denney JM, Mathew L, Goldenberg RL, Culhane JF. Longitudinal trajectory of bacterial vaginosis during pregnancy. Am J Obstet Gynecol. 2008;199(4):431.e431-e435.
34. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198(1):43.e41-e45.
35. Hendler I, Andrews WW, Carey CJ, et al. The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol. 2007;197(5):488.e481-e485.
36. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):375-390.
37. Boggess KA. Pathophysiology of preterm birth: emerging concepts of maternal infection. Clin Perinatol. 2005;32(3):561-569.
38. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004;190(6):1509-1519.
39. Srinivasan U, Misra D, Marazita ML, Foxman B. Vaginal and oral microbes, host genotype and preterm birth. Med Hypotheses. 2009;73(6):963-975.
40. Ryckman KK, Simhan HN, Krohn MA, Williams SM. Cervical cytokine network patterns during pregnancy: the role of bacterial vaginosis and geographic ancestry. J Reprod Immunol. 2009;79(2):174-182.
41. Simhan HN, Caritis SN, Krohn MA, Martinez de Tejada B, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 2003;189(2):560-567.
42. Cauci S, Culhane JF, Di Santolo M, McCollum K. Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta. Am J Obstet Gynecol. 2008;198(1):132.e131-e137.
43. Gomez LM, Sammel MD, Appleby DH, et al. Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol. 2010;202(4):386.e381-e386.
44. Xu J, Holzman CB, Arvidson CG, Chung H, Goepfert AR. Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. Obstet Gynecol. 2008;112(3):524-531.
45. Hitti J, Nugent R, Boutain D, Gardella C, Hillier SL, Eschenbach DA. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol. 2007;21(4):330-337.
46. Morency A-M, Bujold E. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can. 2007;29(1):35-44.
47. Shennan A, Crawshaw S, Briley A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006;113(1):65-74.
48. Diaz-Cueto L, Dominguez-Lopez P, Tena-Alavez G, Cuica-Flores A, Rosales-Ortiz S, Arechavaleta-Velasco F. Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test. Int J Gynaecol Obstet. 2009;107(2):143-146.
49. Gülmezoglu AM, Azhar M. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev. 2002;2002(3): CD000220. doi.
50. Ugwumadu A. Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):391-402.
51. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(3):214-219.
52. Heller DS, Pitsos M, Skurnick J. Does the presence of vaginitis on a Pap smear correlate with clinical symptoms in the patient? J Reprod Med. 2008;53(6):429-434.
53. Darwish A, Elnshar EM, Hamadeh SM, Makarem MH. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. J Obstet Gynaecol Res. 2007;33(6):781-787.
54. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995;172(2 pt 1):525-529.
55. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol. 2006;107(5):1120-1138.
56. King TL, Mitchell AM, Lannen BJ, Daley M. Anti-infectives. In: King TL, Brucker MC, eds. Pharmacology for Women's Health. Sudbury, MA Jones & Bartlett; 2011:249-309.
57. Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. J Womens Health (Larchmt). 2009;18(11):1817-1824.
58. Bunge KE, Beigi RH, Meyn LA, Hillier SL. The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis. 2009;36(11):711-713.
59. Donders G. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv. 2010;65(7):462-473.
60. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194(5):1283-1289.
61. Melvin L, Glasier A, Elton R, Cameron ST. pH-balanced tampons: do they effectively control vaginal pH? BJOG. 2008;115(5):639-645.
62. Krauss-Silva L, Moreira MEL, Alves MB, et al. Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol. Reprod Health. 2010;7:14.
63. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev. 2009(4):CD006289. doi.
64. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol. 2010;203(2):120.e121-e126.
65. Simbar M, Azarbad Z, Mojab F, Majd HA. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis. Phytomedicine. 2008;15(12):1025-1031.
66. Shahin AY, Hassanin IM, Ismail AM, Kruessel JS, Hirchenhain J. Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. Int J Gynaecol Obstet. 2009;104(1):44-48.
67. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971-11975.
68. Long-Smith CM, Sullivan AM, Nolan YM. The influence of microglia on the pathogenesis of Parkinson's disease. Prog Neurobiol. 2009;89(3):277-287.